The Discounted Cash Flow (DCF) valuation of Jiangsu Lianhuan Pharmaceutical Co Ltd (600513.SS) is 5.67 CNY. With the latest stock price at 9.35 CNY, the upside of Jiangsu Lianhuan Pharmaceutical Co Ltd based on DCF is -39.4%.
Based on the latest price of 9.35 CNY and our DCF valuation, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513.SS) is a sell. selling 600513.SS stocks now will result in a potential gain of 39.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 9.6% | 8.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 4.08 - 8.42 | 5.67 |
| Upside | -56.4% - -10.0% | -39.4% |